Bulasa, Antonite A.

HRN: 22-90-45  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2024
CEFUROXIME 500MG (TAB)
03/25/2024
04/01/2024
PO
500mg
BID X 7 Days
Thickly Meconium Stained Amniotic Fluid
Waiting Final Action 
03/25/2024
METRONIDAZOLE 500MG (TAB)
03/25/2024
04/01/2024
PO
500mg
TID X 7 Days
Thickly Meconium Stained Amniotic Fluid
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: